Total Payments
$3,328
2024 Payments
$59.53
Companies
5
Transactions
20
Medicare Patients
6,541
Medicare Billing
$386,540
Payment Breakdown by Category
Consulting$2,500 (75.1%)
Food & Beverage$424.52 (12.8%)
Travel$403.34 (12.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $2,500 | 1 | 75.1% |
| Food and Beverage | $424.52 | 17 | 12.8% |
| Travel and Lodging | $403.34 | 2 | 12.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Optinose US, Inc. | $3,151 | 11 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $86.78 | 5 | $0 (2019) |
| Stryker Corporation | $37.94 | 2 | $0 (2024) |
| Lannett Company Inc | $37.01 | 1 | $0 (2017) |
| GlaxoSmithKline, LLC. | $15.00 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $59.53 | 3 | Optinose US, Inc. ($34.70) |
| 2021 | $15.00 | 1 | GlaxoSmithKline, LLC. ($15.00) |
| 2019 | $3,145 | 11 | OptiNose US, Inc. ($3,116) |
| 2018 | $57.90 | 3 | Novartis Pharmaceuticals Corporation ($57.90) |
| 2017 | $50.90 | 2 | Lannett Company Inc ($37.01) |
All Payment Transactions
20 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/23/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 04/10/2024 | Stryker Corporation | AUDION ET DILATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $24.83 | General |
| Category: ENTELLUS | ||||||
| 02/26/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 08/18/2021 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/01/2019 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $5.87 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 06/28/2019 | Novartis Pharmaceuticals Corporation | CIPRODEX (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: OTOLARYNGOLOGY | ||||||
| 05/16/2019 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $66.87 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 05/16/2019 | OptiNose US, Inc. | Xhance (Drug) | Travel and Lodging | Cash or cash equivalent | $30.00 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 05/03/2019 | OptiNose US, Inc. | Xhance (Drug) | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 04/28/2019 | OptiNose US, Inc. | Xhance (Drug) | Travel and Lodging | In-kind items and services | $373.34 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 04/27/2019 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $49.31 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 04/27/2019 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $40.00 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 04/27/2019 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $30.52 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 04/27/2019 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 04/09/2019 | Stryker Corporation | ENTELLUS - XPRESS ENT DILATION SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $13.11 | General |
| Category: ENTELLUS | ||||||
| 12/10/2018 | Novartis Pharmaceuticals Corporation | CIPRODEX (Drug) | Food and Beverage | In-kind items and services | $22.85 | General |
| Category: OTOLARYNGOLOGY | ||||||
| 09/11/2018 | Novartis Pharmaceuticals Corporation | CIPRODEX (Drug) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: OTOLARYNGOLOGY | ||||||
| 05/01/2018 | Novartis Pharmaceuticals Corporation | CIPRODEX (Drug) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: OTOLARYNGOLOGY | ||||||
| 11/15/2017 | Novartis Pharmaceuticals Corporation | CIPRODEX (Drug) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: OTOLARYNGOLOGY | ||||||
| 04/19/2017 | Lannett Company Inc | C Topical Solution 4 CII (Drug) | Food and Beverage | Cash or cash equivalent | $37.01 | General |
| Category: Topical Anesthetics | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,716 | 1,956 | $459,708 | $95,283 |
| 2022 | 14 | 1,733 | 2,002 | $410,692 | $104,745 |
| 2021 | 13 | 1,796 | 2,083 | $407,211 | $112,305 |
| 2020 | 11 | 1,296 | 1,475 | $215,974 | $74,207 |
Total Patients
6,541
Total Services
7,516
Medicare Billing
$386,540
Procedure Codes
52
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 69210 | Removal of impacted ear wax | Office | 2023 | 535 | 679 | $108,137 | $18,518 | 17.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 229 | 229 | $70,470 | $13,794 | 19.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 205 | 237 | $54,620 | $12,132 | 22.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 93 | 93 | $39,543 | $9,410 | 23.8% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2023 | 88 | 101 | $37,898 | $7,806 | 20.6% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2023 | 106 | 117 | $43,323 | $7,660 | 17.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 176 | 206 | $23,150 | $7,119 | 30.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 85 | 92 | $29,991 | $6,666 | 22.2% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 129 | 129 | $21,897 | $5,424 | 24.8% |
| 30901 | Simple control of nose bleed | Office | 2023 | 24 | 26 | $11,781 | $2,027 | 17.2% |
| 30903 | Complex control of nose bleed | Office | 2023 | 14 | 14 | $7,736 | $2,007 | 25.9% |
| 69420 | Incision, aspiration, and/or inflation of eardrum | Office | 2023 | 12 | 13 | $6,206 | $1,729 | 27.9% |
| 69200 | Removal of foreign body in ear canal | Office | 2023 | 20 | 20 | $4,956 | $991.21 | 20.0% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 568 | 719 | $95,120 | $21,072 | 22.2% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2022 | 107 | 123 | $43,596 | $11,883 | 27.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 170 | 202 | $41,787 | $10,870 | 26.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 95 | 95 | $34,702 | $10,397 | 30.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 152 | 152 | $41,745 | $10,080 | 24.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 228 | 274 | $29,868 | $9,795 | 32.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 95 | 104 | $27,227 | $9,044 | 33.2% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2022 | 96 | 102 | $35,442 | $7,504 | 21.2% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 147 | 147 | $23,642 | $5,998 | 25.4% |
| 30903 | Complex control of nose bleed | Office | 2022 | 15 | 17 | $9,690 | $2,431 | 25.1% |
| 69420 | Incision, aspiration, and/or inflation of eardrum | Office | 2022 | 15 | 18 | $10,480 | $2,380 | 22.7% |
| 30901 | Simple control of nose bleed | Office | 2022 | 18 | 19 | $7,480 | $1,764 | 23.6% |
About Dr. Bert Brown, M.D
Dr. Bert Brown, M.D is a Otolaryngology healthcare provider based in Mayfield Hts, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/03/2005. The National Provider Identifier (NPI) number assigned to this provider is 1114928900.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bert Brown, M.D has received a total of $3,328 in payments from pharmaceutical and medical device companies, with $59.53 received in 2024. These payments were reported across 20 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($2,500).
As a Medicare-enrolled provider, Brown has provided services to 6,541 Medicare beneficiaries, totaling 7,516 services with total Medicare billing of $386,540. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Ad
Practice Information
- Specialty Otolaryngology
- Location Mayfield Hts, OH
- Active Since 08/03/2005
- Last Updated 06/15/2015
- Taxonomy Code 207Y00000X
- Entity Type Individual
- NPI Number 1114928900
Products in Payments
- Xhance (Drug) $3,151
- CIPRODEX (Drug) $86.78
- C Topical Solution 4 CII (Drug) $37.01
- AUDION ET DILATION SYSTEM (Device) $24.83
- NUCALA (Biological) $15.00
- ENTELLUS - XPRESS ENT DILATION SYSTEM (Device) $13.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.